FEED
ENvue Medical, Inc.
Price Chart
Latest Quote
$0.70
+0.03 (+4.26%)
Current Price
| Previous Close | $0.67 |
| Open | $0.68 |
| Day High | $0.75 |
| Day Low | $0.67 |
| Volume | 427,322 |
Stock Information
| Shares Outstanding | 6.09M |
| Total Debt | $1.21M |
| Cash Equivalents | $2.23M |
| Revenue | $2.18M |
| Net Income | $-37.52M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $4.26M |
| EPS (TTM) | $-3.62 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $3.24M |
| Sales | $2.18M |
| Income | $-37.52M |
| Book/sh | $8.65 |
| Cash/sh | $0.37 |
| Employees | 12 |
Financial Ratios
| Quick Ratio | 0.43 |
| Current Ratio | 0.90 |
| Debt/Eq | 3.78 |
Returns & Margins
| ROA | -20.23% |
| ROE | -59.49% |
| Gross Margin | -12.43% |
| Operating Margin | -568.30% |
Ownership
| Insider Ownership | 5.42% |
| Institutional Ownership | 1.04% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 1.96 |
| P/B | 0.08 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.84 |
| SMA50 | $1.11 |
| SMA200 | $3.12 |
| RSI | 31.86 |
| ATR | 0.0966 |
| Shares Float | 5.85M |
| Short Float | 1.06% |
| Short Ratio | 0.10 |
| Volatility | 1.50 |
| Rel Volume | 0.24 |
Performance History
| Week | -15.55% |
| Month | -24.80% |
| Quarter | -41.66% |
| 6 Months | -79.37% |
| YTD | -71.42% |
| Year | -92.66% |
| 3 Years | -99.81% |
| 5 Years | -99.97% |
| 10 Years | -99.99% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $0.70 | 427,322 |
| 2026-06-18 | $0.67 | 498,300 |
| 2026-06-17 | $0.73 | 313,600 |
| 2026-06-16 | $0.77 | 266,600 |
| 2026-06-15 | $0.80 | 363,800 |
| 2026-06-12 | $0.83 | 459,800 |
| 2026-06-11 | $0.88 | 709,100 |
| 2026-06-10 | $0.85 | 2,147,900 |
| 2026-06-09 | $0.75 | 22,836,400 |
| 2026-06-08 | $0.79 | 321,400 |
| 2026-06-05 | $0.87 | 336,000 |
| 2026-06-04 | $0.85 | 398,900 |
| 2026-06-03 | $0.86 | 5,430,400 |
| 2026-06-02 | $0.90 | 107,000 |
| 2026-06-01 | $0.90 | 101,600 |
| 2026-05-29 | $0.90 | 122,200 |
| 2026-05-28 | $0.93 | 169,600 |
| 2026-05-27 | $0.92 | 101,600 |
| 2026-05-26 | $0.93 | 234,600 |
About ENvue Medical, Inc.
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at-home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures. In addition, it provides WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Europe, Australia, Israel, New Zealand, and internationally. The company was formerly known as NanoVibronix, Inc. and changed its name to ENvue Medical, Inc. in December 2025. The company was incorporated in 2003 and is based in Tyler, Texas.
đ° Latest News
EXCLUSIVE: ENvue Medical Says Health System Renewal Extends Platform Adoption Through 2028
Benzinga âĸ 2026-05-13T12:31:06Z
BC-Most Active Stocks
Associated Press Finance âĸ 2026-03-24T14:30:18ZENvue Medical Insider Ups Holding During Year
Simply Wall St. âĸ 2026-02-14T13:10:15Z
ENvue Medical announces launch of new development, integration program
TipRanks âĸ 2026-01-10T14:10:15Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $2,400,000 | $1,050,000 | $746,000 | $585,000 |
| Cost Of Revenue | $2,400,000 | $1,050,000 | $746,000 | $585,000 |
| Total Revenue | $2,553,000 | $2,558,000 | $2,283,000 | $752,000 |
| Operating Revenue | $2,553,000 | $2,558,000 | $2,283,000 | $752,000 |
| Expenses | ||||
| Total Expenses | $14,288,000 | $6,140,000 | $5,719,000 | $5,764,000 |
| Other Income Expense | $-11,154,000 | - | - | - |
| Net Non Operating Interest Income Expense | $4,397,000 | $-104,000 | $-246,000 | $-401,000 |
| Total Other Finance Cost | $-4,397,000 | $104,000 | $111,000 | $54,000 |
| Operating Expense | $11,888,000 | $5,090,000 | $4,973,000 | $5,179,000 |
| Selling And Marketing Expense | $2,493,000 | $720,000 | $864,000 | $965,000 |
| General And Administrative Expense | $7,633,000 | $3,461,000 | $3,924,000 | $3,931,000 |
| Interest Expense | - | $135,000 | $135,000 | $347,000 |
| Interest Expense Non Operating | - | $135,000 | $135,000 | $347,000 |
| Other Non Operating Income Expenses | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-18,185,000 | $-3,705,000 | $-3,711,000 | $-5,448,000 |
| Net Interest Income | $4,397,000 | $-104,000 | $-246,000 | $-401,000 |
| Normalized Income | $-7,216,156 | $-3,705,000 | $-3,711,000 | $-5,448,000 |
| Net Income From Continuing And Discontinued Operation | $-18,185,000 | $-3,705,000 | $-3,711,000 | $-5,448,000 |
| Total Operating Income As Reported | $-22,889,000 | $-3,582,000 | $-3,436,000 | $-5,012,000 |
| Net Income Common Stockholders | $-16,775,000 | $-3,705,000 | $-3,711,000 | $-5,448,000 |
| Net Income | $-18,185,000 | $-3,705,000 | $-3,711,000 | $-5,448,000 |
| Net Income Including Noncontrolling Interests | $-18,185,000 | $-3,705,000 | $-3,711,000 | $-5,448,000 |
| Net Income Continuous Operations | $-18,185,000 | $-3,705,000 | $-3,711,000 | $-5,448,000 |
| Pretax Income | $-18,492,000 | $-3,686,000 | $-3,682,000 | $-5,413,000 |
| Special Income Charges | $-11,154,000 | $0 | - | $0 |
| Operating Income | $-11,735,000 | $-3,582,000 | $-3,436,000 | $-5,012,000 |
| Gross Profit | $153,000 | $1,508,000 | $1,537,000 | $167,000 |
| Per Share | ||||
| Diluted EPS | $-26.69 | $-137.30 | $-233.20 | $-422.40 |
| Basic EPS | $-26.69 | $-137.30 | $-233.20 | $-422.40 |
| Other | ||||
| Tax Effect Of Unusual Items | $-185,156 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $316,000 | $-3,581,000 | $-3,546,000 | $-5,065,000 |
| Total Unusual Items | $-11,154,000 | $0 | - | $0 |
| Total Unusual Items Excluding Goodwill | $-11,154,000 | $0 | - | $0 |
| Reconciled Depreciation | $897,000 | $1,000 | $1,000 | $1,000 |
| EBITDA (Bullshit earnings) | $-10,838,000 | $-3,581,000 | $-3,546,000 | $-5,065,000 |
| EBIT | $-11,735,000 | $-3,582,000 | $-3,547,000 | $-5,066,000 |
| Diluted Average Shares | $628,534 | $26,985 | $15,910 | $12,906 |
| Basic Average Shares | $628,534 | $26,985 | $15,910 | $12,906 |
| Diluted NI Availto Com Stockholders | $-16,775,000 | $-3,705,000 | $-3,711,000 | $-5,448,000 |
| Otherunder Preferred Stock Dividend | $-3,506,000 | $0 | - | - |
| Preferred Stock Dividends | $2,096,000 | - | - | - |
| Tax Provision | $-307,000 | $19,000 | $29,000 | $35,000 |
| Impairment Of Capital Assets | $11,154,000 | $0 | - | - |
| Research And Development | $1,762,000 | $909,000 | $185,000 | $283,000 |
| Selling General And Administration | $10,126,000 | $4,181,000 | $4,788,000 | $4,896,000 |
| Other Gand A | $7,633,000 | $3,461,000 | $3,924,000 | $3,931,000 |
| Other Special Charges | - | - | - | - |
| Gain On Sale Of Security | - | - | - | - |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $35,000 | $627,000 | $3,988,000 | $3,233,000 |
| Total Assets | $41,124,000 | $3,629,000 | $6,674,000 | $5,879,000 |
| Total Non Current Assets | $33,853,000 | $298,000 | $187,000 | $270,000 |
| Non Current Accounts Receivable | $20,000 | - | - | - |
| Goodwill And Other Intangible Assets | $33,462,000 | $0 | - | - |
| Other Intangible Assets | $4,380,000 | - | - | - |
| Current Assets | $7,271,000 | $3,331,000 | $6,487,000 | $5,609,000 |
| Restricted Cash | $30,000 | $0 | - | - |
| Prepaid Assets | $137,000 | $120,000 | $47,000 | $612,000 |
| Inventory | $2,337,000 | $2,191,000 | $2,732,000 | $2,175,000 |
| Receivables | $543,000 | $268,000 | $425,000 | $109,000 |
| Other Receivables | $254,000 | $170,000 | $107,000 | $100,000 |
| Accounts Receivable | $289,000 | $98,000 | $318,000 | $9,000 |
| Cash Cash Equivalents And Short Term Investments | $4,224,000 | $752,000 | $3,283,000 | $2,713,000 |
| Cash And Cash Equivalents | $4,224,000 | $752,000 | $3,283,000 | $2,713,000 |
| Cash Financial | $4,224,000 | $752,000 | $3,283,000 | $2,713,000 |
| Other Non Current Assets | - | - | $1,000 | $3,000 |
| Debt | ||||
| Total Debt | $1,197,000 | $116,000 | $5,000 | $81,000 |
| Long Term Debt And Capital Lease Obligation | $28,000 | $64,000 | $0 | - |
| Current Debt And Capital Lease Obligation | $1,169,000 | $52,000 | $5,000 | $81,000 |
| Current Debt | $1,080,000 | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $7,627,000 | $3,002,000 | $2,686,000 | $2,646,000 |
| Total Non Current Liabilities Net Minority Interest | $967,000 | $280,000 | $232,000 | $330,000 |
| Derivative Product Liabilities | $807,000 | - | - | - |
| Current Liabilities | $6,660,000 | $2,722,000 | $2,454,000 | $2,316,000 |
| Other Current Liabilities | $2,252,000 | $2,117,000 | - | - |
| Current Deferred Liabilities | $175,000 | $15,000 | $46,000 | $21,000 |
| Current Notes Payable | $1,080,000 | $0 | - | - |
| Payables And Accrued Expenses | $3,064,000 | $538,000 | $2,403,000 | $2,214,000 |
| Payables | $1,086,000 | $47,000 | $2,403,000 | $2,214,000 |
| Other Payable | $250,000 | $2,608,000 | $2,265,000 | $2,148,000 |
| Total Tax Payable | $117,000 | $0 | - | - |
| Accounts Payable | $719,000 | $47,000 | $138,000 | $66,000 |
| Non Current Deferred Liabilities | - | $0 | $15,000 | $107,000 |
| Equity | ||||
| Common Stock Equity | $33,497,000 | $627,000 | $3,988,000 | $3,233,000 |
| Total Equity Gross Minority Interest | $33,497,000 | $627,000 | $3,988,000 | $3,233,000 |
| Stockholders Equity | $33,497,000 | $627,000 | $3,988,000 | $3,233,000 |
| Gains Losses Not Affecting Retained Earnings | $-80,000 | $-80,000 | $-67,000 | $-18,000 |
| Other Equity Adjustments | $-80,000 | $-80,000 | $-67,000 | $-18,000 |
| Retained Earnings | $-90,481,000 | $-69,801,000 | $-66,096,000 | $-62,385,000 |
| Other | ||||
| Ordinary Shares Number | $1,100,413 | $37,894 | $18,602 | $14,919 |
| Share Issued | $1,100,413 | $378,940 | $18,602 | $14,919 |
| Tangible Book Value | $35,000 | $627,000 | $3,988,000 | $3,233,000 |
| Invested Capital | $34,577,000 | $627,000 | $3,988,000 | $3,233,000 |
| Working Capital | $611,000 | $609,000 | $4,033,000 | $3,293,000 |
| Capital Lease Obligations | $117,000 | $116,000 | $5,000 | $81,000 |
| Total Capitalization | $33,497,000 | $627,000 | $3,988,000 | $3,233,000 |
| Additional Paid In Capital | $124,057,000 | $70,507,000 | $70,149,000 | $65,634,000 |
| Capital Stock | $1,000 | $1,000 | $2,000 | $2,000 |
| Common Stock | $1,000 | $1,000 | $2,000 | $2,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Employee Benefits | $132,000 | $216,000 | $217,000 | $223,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $132,000 | $216,000 | $217,000 | $223,000 |
| Long Term Capital Lease Obligation | $28,000 | $64,000 | $0 | - |
| Current Deferred Revenue | $175,000 | $15,000 | $46,000 | $21,000 |
| Current Capital Lease Obligation | $89,000 | $52,000 | $5,000 | $81,000 |
| Current Accrued Expenses | $1,978,000 | $491,000 | - | - |
| Defined Pension Benefit | $125,000 | $173,000 | $174,000 | $179,000 |
| Goodwill | $29,082,000 | $0 | - | - |
| Net PPE | $246,000 | $125,000 | $12,000 | $88,000 |
| Gross PPE | $246,000 | $125,000 | $12,000 | $88,000 |
| Other Properties | $246,000 | $125,000 | $12,000 | $88,000 |
| Finished Goods | $536,000 | $729,000 | $2,522,000 | $2,145,000 |
| Raw Materials | $1,801,000 | $1,462,000 | $210,000 | $30,000 |
| Non Current Deferred Revenue | - | $0 | $15,000 | $107,000 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-9,432,000 | $-2,519,000 | $-3,603,000 | $-7,038,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-9,372,000 | $-2,516,000 | $-3,602,000 | $-7,035,000 |
| Cash Flow From Continuing Operating Activities | $-9,369,000 | $-2,516,000 | $-3,602,000 | $-7,035,000 |
| Operating Gains Losses | $-6,204,000 | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-60,000 | $-3,000 | $-1,000 | $-3,000 |
| Investing Cash Flow | $88,000 | $-3,000 | $-1,000 | $-3,000 |
| Cash Flow From Continuing Investing Activities | $88,000 | $-3,000 | $-1,000 | $-3,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-5,000,000 | $0 | - | - |
| Issuance Of Capital Stock | $19,089,000 | $0 | $4,215,000 | $2,090,000 |
| Financing Cash Flow | $12,786,000 | $1,000 | $4,222,000 | $2,092,000 |
| Cash Flow From Continuing Financing Activities | $12,786,000 | $1,000 | $4,222,000 | $2,092,000 |
| Net Other Financing Charges | $12,000 | - | - | - |
| Net Preferred Stock Issuance | $-5,000,000 | $0 | - | - |
| Net Common Stock Issuance | $19,089,000 | $0 | $4,215,000 | $2,090,000 |
| Common Stock Issuance | $19,089,000 | $0 | $4,215,000 | $2,090,000 |
| Other | ||||
| Repayment Of Debt | $-3,077,000 | $0 | - | - |
| Issuance Of Debt | $1,660,000 | $0 | - | - |
| Interest Paid Supplemental Data | $25,000 | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $52,000 | $0 | $0 | $0 |
| End Cash Position | $4,254,000 | $752,000 | $3,283,000 | $2,713,000 |
| Beginning Cash Position | $752,000 | $3,283,000 | $2,713,000 | $7,737,000 |
| Effect Of Exchange Rate Changes | $0 | $-13,000 | $-49,000 | $-78,000 |
| Changes In Cash | $3,502,000 | $-2,518,000 | $619,000 | $-4,946,000 |
| Proceeds From Stock Option Exercised | $102,000 | $1,000 | $7,000 | $2,000 |
| Preferred Stock Payments | $-5,000,000 | $0 | - | - |
| Net Issuance Payments Of Debt | $-1,417,000 | $0 | - | - |
| Net Short Term Debt Issuance | $-117,000 | $0 | - | - |
| Short Term Debt Payments | $-1,777,000 | $0 | - | - |
| Short Term Debt Issuance | $1,660,000 | $0 | - | - |
| Net Long Term Debt Issuance | $-1,300,000 | $0 | - | - |
| Long Term Debt Payments | $-1,300,000 | $0 | - | - |
| Net Business Purchase And Sale | $148,000 | $0 | - | - |
| Sale Of Business | $148,000 | $0 | - | - |
| Net PPE Purchase And Sale | $-60,000 | $-3,000 | $-1,000 | $-3,000 |
| Purchase Of PPE | $-60,000 | $-3,000 | $-1,000 | $-3,000 |
| Change In Working Capital | $1,664,000 | $731,000 | $-322,000 | $-2,305,000 |
| Change In Other Working Capital | $160,000 | $-46,000 | $-67,000 | $-69,000 |
| Change In Other Current Liabilities | $-85,000 | $-34,000 | - | - |
| Change In Other Current Assets | $74,000 | $34,000 | - | - |
| Change In Payables And Accrued Expense | $1,541,000 | $151,000 | $53,000 | $55,000 |
| Change In Accrued Expense | $-36,000 | $0 | $-1,000 | $-2,000 |
| Change In Payable | $1,577,000 | $151,000 | $54,000 | $57,000 |
| Change In Account Payable | $552,000 | $-91,000 | $72,000 | $-21,000 |
| Change In Inventory | $249,000 | $541,000 | $-557,000 | $-2,000,000 |
| Change In Receivables | $-275,000 | $85,000 | $249,000 | $-291,000 |
| Changes In Account Receivables | $-179,000 | $221,000 | $-309,000 | $191,000 |
| Other Non Cash Items | $1,675,000 | $101,000 | $135,000 | $347,000 |
| Stock Based Compensation | $0 | $356,000 | $293,000 | $354,000 |
| Asset Impairment Charge | $11,154,000 | $0 | - | - |
| Deferred Tax | $-373,000 | $0 | - | - |
| Deferred Income Tax | $-373,000 | $0 | - | - |
| Depreciation Amortization Depletion | $897,000 | $1,000 | $1,000 | $1,000 |
| Depreciation And Amortization | $897,000 | $1,000 | $1,000 | $1,000 |
| Gain Loss On Investment Securities | $-6,204,000 | - | - | - |
| Net Income From Continuing Operations | $-18,185,000 | $-3,705,000 | $-3,711,000 | $-5,448,000 |
| Unrealized Gain Loss On Investment Securities | - | $0 | $2,000 | $16,000 |
| Long Term Debt Issuance | - | - | - | - |
Fetched: 2026-06-18